CDIA
ZBH icon

Capital Directions Investment Advisors’s Zimmer Biomet ZBH Stock Holding History

Capital Directions Investment Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-101
Closed -$13K – 277
2022
Q1 		$13K Buy
+101
New +$12.2K ﹤0.01% 223

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Directions Investment Advisors's ZBH Position: Q2 2022 in Review

Capital Directions Investment Advisors sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 101 shares — an estimated $13K sold.

Capital Directions Investment Advisors first reported a position in ZBH in Q1 2022 and held it in 1 quarter. The position peaked at $13K in Q1 2022. 957 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

  • Capital Directions Investment Advisors reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
  • Capital Directions Investment Advisors sold 101 Zimmer Biomet shares in Q2 2022, an estimated $13K.
  • Capital Directions Investment Advisors first reported a position in Zimmer Biomet in Q1 2022 and held it in 1 quarter.
  • Capital Directions Investment Advisors's Zimmer Biomet position peaked at $13K in Q1 2022.
  • 957 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Capital Directions Investment Advisors's 13F filing for Q2 2022, filed 26 Jul 2022.